Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 14/20 | 1.00 |
| ▸ | CDK5R1 | Q15078 | 14/20 | 1.00 |
| ▸ | CCNA2 | P20248 | 13/20 | 1.00 |
| ▸ | CDK2 | P24941 | 13/20 | 1.00 |
| ▸ | CCNA1 | P78396 | 13/20 | 1.00 |
| ▸ | CDK1 | P06493 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | CCNB2 | O95067 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CCNB1 | P14635 | 3/20 | 1.00 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 1.00 |
| ▸ | CCNE2 | O96020 | 2/20 | 1.00 |
| ▸ | INSR | P06213 | 2/20 | 1.00 |
| ▸ | PRKACA | P17612 | 2/20 | 1.00 |
| ▸ | PRKACG | P22612 | 2/20 | 1.00 |
| ▸ | PRKACB | P22694 | 2/20 | 1.00 |
| ▸ | CCNE1 | P24864 | 2/20 | 1.00 |
| ▸ | MAPK3 | P27361 | 2/20 | 1.00 |
| ▸ | NTRK1 | P04629 | 1/20 | 1.00 |
| ▸ | NTRK2 | Q16620 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Purvalanol B SCHEMBL23509845 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Purvalanol B SCHEMBL29546074 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Purvalanol B SCHEMBL6932922 | 1.00 | CDK5 (1.00) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL13498146 | 0.93 | CDK5 (0.87) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL13497847 | 0.92 | CDK5 (0.86) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL14845886 | 0.91 | CDK5 (0.84) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL569370 | 0.90 | CDK5 (0.81) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL17603568 | 0.87 | CDK5 (0.78) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL20694113 | 0.87 | CDK5 (0.77) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL13497968 | 0.85 | CDK5 (0.73) | CDK5CDK5R1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2216 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250116671-A1 | Kinase Activity In Tumors | INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER (US) | 2025-04-10 | — | — | US | claimed |
| EP-4529926-A1 | METHOD FOR TREATING CANCER BY COMBINING ALKYLATING AGENT PRODRUG AND CELL CYCLE INHIBITOR | Ascentawits Pharmaceuticals, Ltd. (CN) | 2025-04-02 | — | — | EP | claimed |
| WO-2025051337-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ORAL CANCER | Afyx Development A/S (DK) | 2025-03-13 | — | — | WO | claimed |
| US-12187698-B2 | Crystalline forms of C21H22Cl2N4O2 | BIOMED VALLEY DISCOVERIES, INC. (US) | 2025-01-07 | — | — | US | claimed |
| CN-119233822-A | Methods of treating cancer using alkylating agent prodrugs and cell cycle inhibitors in combination | 深圳艾欣达伟医药科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| US-20240299558-A1 | PROTEOLYSIS TARGETING CHIMERAS AND POLYPHARMACOLOGICAL AGENTS TARGETING BCL-2, AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-09-12 | — | — | US | claimed |
| US-20240293557-A1 | PROTEOLYSIS TARGETING CHIMERAS AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE | 2024-09-05 | — | — | US | claimed |
| US-20240287615-A1 | CANCER METHODS | UNIVERSITY COLLEGE LONDON (GB) | 2024-08-29 | — | — | US | claimed |
| EP-3554526-B1 | LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2024-05-08 | — | — | EP | claimed |
| EP-4355423-A1 | PRECISION MEDICINE FOR SCHIZOPHRENIA AND PSYCHOTIC DISORDERS: OBJECTIVE ASSESSMENT, RISK PREDICTION, PHARMACOGENOMICS, AND REPURPOSED DRUGS | Indiana University Research and Technology Corporation (US) | 2024-04-24 | — | — | EP | claimed |
| WO-2003077999-A1 | COMBINATION OFA CDK INHIBITOR AND 5-FU FOR THE TREATMENT OF CANCER | CYCLACEL LIMITED (GB) | 2003-09-25 | — | — | WO | claimed |
| US-20030125374-A1 | Enhancement of taxane-based chemotherapy by a CDK1 antagonist | YALE UNIVERSITY | 2003-07-03 | — | — | US | claimed |
| US-20030099944-A1 | Combination therapy involving drugs which target cellular proteins and drugs which target pathogen-encoded proteins | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2003-05-29 | — | — | US | claimed |
| WO-2003039536-A1 | ENHANCEMENT OF TAXANE-BASED CHEMOTHERAPY BY A CDK1 ANTAGONIST | YALE UNIVERSITY (US) | 2003-05-15 | — | — | WO | claimed |
| WO-2003027317-A2 | USE OF ACTIVE SUBSTANCES FOR THE PROPHYLAXIS AND/OR TREATMENT OF DISEASES CAUSED BY CELL GROWTH DISTURBANCES AND TEST SYSTEM FOR DISCOVERY OF SAID ACTIVE SUBSTANCES | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH (DE) | 2003-04-03 | — | — | WO | claimed |
| US-20030060457-A1 | Cellular proteins as targets for the treatment of pathogens resistant to drugs that target pathogen-encoded proteins | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | 2003-03-27 | — | — | US | claimed |
| WO-2003015689-A2 | PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF VIRUS DISEASES | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH (DE) | 2003-02-27 | — | — | WO | claimed |
| WO-2002089779-A2 | COMBINED PREPARATION FOR THE PROPHYLAXIS AND/OR THERAPY OF NERVE CELL AND/OR GLIA CELL DAMAGE USING A NOVEL METHOD OF TREATMENT | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH (DE) | 2002-11-14 | — | — | WO | claimed |
| WO-2002053096-A2 | SINGLE THERAPY AND COMBINATION THERAPY INVOLVING DRUGS WITH TARGET CELLULAR PROTEINS AND DRUGS WHICH TARGET PATHOGEN-ENCODED PROTEINS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2002-07-11 | — | — | WO | claimed |
| WO-2002030410-A2 | SUPPRESSION OF CYCLIN KINASE ACTIVITY FOR PREVENTION AND TREATMENT OF INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-04-18 | — | — | WO | claimed |